Articles tagged with “genomics”

Get a detailed list of biotech companies in Toronto (2026). Learn about the life sciences ecosystem, top startups in AI and genomics, and key industry players.

Explore San Diego's biotech hub, a top 3 U.S. cluster. This guide covers key companies like Illumina, economic data, and the history of its life sciences indust

Explore the top MCP servers for biotech. Learn how the Model Context Protocol connects AI agents and LLMs to critical databases for genomics and drug discovery.

Explore the exponential rise in AI compute demand in biotech. This 2025 report analyzes key statistics, infrastructure needs, and trends in drug discovery and g

An educational guide to HPC in life sciences. We review top lab IT specialists and solutions for genomics, drug discovery, and bioinformatics data analysis.

Explore AWS cloud computing's role in life sciences for scalable data processing, HPC, and analytics. Learn how AWS facilitates innovation in biotech and pharma.

Learn about key technical, regulatory, organizational, ethical, and financial barriers hindering AI adoption in life sciences, with emerging solutions.

How AI leaders like Amodei, Hassabis, and Huang are accelerating drug discovery, genomics, and life science breakthroughs—compressing decades into years.

A detailed survey of large language model benchmarks in life sciences, covering biomedical NLP, drug discovery, and genomics, with industry use cases and top model performance.

Comprehensive analysis of big data technologies used in pharmaceutical industry, including Hadoop, Spark 4.x, cloud data warehouses (Snowflake, Databricks), NoSQL databases, and specialized genomics platforms, with detailed comparisons and implementation examples. Updated for 2025-2026 with latest market data and technology developments.

An in-depth exploration of how data science is revolutionizing the life sciences industry, from drug discovery to clinical trials, with real-world applications and case studies. Updated January 2026 with latest FDA AI guidance, Insilico Medicine Phase IIa results, and major industry consolidations.